Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia

Conclusions: This case of a 46,XX patient raised as male with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency highlights a number of unique and difficult treatment challenges; specifically, the role of new therapeutic options for optimization of growth in the context of prior suboptimal disease management.
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Source Type: research